ARYx Therapeutics Stock Forecast for 2023 - 2025 - 2030

Updated on 05/17/2024

Stock Rating
0
Price Target
$0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
0
Upside
0.00%
Analysts
0
Price Target
$0.00
-

ARYx Therapeutics Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, ARYx Therapeutics's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that ARYx Therapeutics's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$771.12 Buy/Sell $636.99 13.80%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$154.28 Buy/Sell $174.55 10.19%
MRK Stock Forecast Merck Outperform 2
$130.88 Buy/Sell $130.51 9.26%
PFE Stock Forecast Pfizer Outperform 2
$28.92 Buy/Sell $32.87 5.46%
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 12
$440.64 Buy/Sell $457.59 3.76%

ARYx Therapeutics Revenue Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
REGN Stock Forecast Regeneron Pharmaceuticals Outperform 2
$967.98 Buy/Sell $961.26 8.47%
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$44.11 Buy/Sell $58.15 22.42%
ZTS Stock Forecast Zoetis Outperform 18
$173.71 Buy/Sell $220.47 26.65%

ARYx Therapeutics Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$151.22 Buy/Sell $245.24 43.83%
BAX Stock Forecast Baxter International Inc Hold 17
$35.17 Buy/Sell $44.86 25.11%
VTRS Stock Forecast Viatris Inc Hold 8
$11.02 Buy/Sell $11.73 8.89%

ARYx Therapeutics Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
UTHR Stock Forecast United Therapeutics Outperform 12
$272.22 Buy/Sell $284.08 10.20%
CTLT Stock Forecast Catalent Hold 15
$55.25 Buy/Sell $49.29 14.93%
CYTK Stock Forecast Cytokinetics Outperform 10
$59.92 Buy/Sell $87.92 56.88%

ARYx Therapeutics EBITDA Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
IONS Stock Forecast Ionis Pharmaceuticals Outperform 9
$37.62 Buy/Sell $55.60 59.49%
BCPC Stock Forecast Balchem Outperform 18
$156.63 Buy/Sell $145.00 5.34%
MDGL Stock Forecast Madrigal Pharmaceuticals Outperform 4
$217.17 Buy/Sell $315.92 77.74%

ARYx Therapeutics EBIT Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PRGO Stock Forecast Perrigo Co PLC Outperform 16
$30.10 Buy/Sell $44.75 32.89%
NEOG Stock Forecast Neogen Outperform 16
$13.41 Buy/Sell $37.00 26.77%
CORT Stock Forecast Corcept Therapeutics Buy 16
$27.54 Buy/Sell $35.67 45.24%

ARYx Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, ARYx Therapeutics's EPS has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict EPS of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that ARYx Therapeutics's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INDV Stock Forecast Indivior PLC Buy 14
£13.52 Buy/Sell £28.89 128.77%
TGTX Stock Forecast TG Therapeutics Outperform 9
$17.42 Buy/Sell $29.44 98.05%
AMPH Stock Forecast Amphastar Pharmaceuticals Outperform 14
$42.74 Buy/Sell $69.00 45.06%